VMPL Mumbai Maharashtra [India] October 3 Sahajanand Medical Technologies SMT is excited to announce the successful ...

Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and ...

Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...

The University of Alabama at Birmingham startup company Endomimetics, LLC, has received a $2.8 million Small Business ...

The following is a summary of “Bleeding complications, coagulation disorders, and their management in acute myocardial ...

It is crucial for patients to communicate with their healthcare provider about any unusual symptoms and to follow dosing instructions carefully to minimize these risks while benefiting from the ...

The improvement of our knowledge on the pharmacodynamics of antiplatelet drugs enables the tailoring of the most appropriate antithrombotic therapy to the individual patient and risk situation in ...

Sahajanand Medical Technologies successfully completed enrollment of 1,550 patients for the Multivessel TALENT trial, ...

Various clinical, demographic and genetic variables can influence responsiveness to antiplatelet therapy. In 2008, Geisler et al. 10 showed that residual platelet activity in patients with ...

In this randomized controlled trial, among ischemic stroke patients treated with intravenous thrombolysis, it was found that ...

Antiplatelet therapy is the mainstay of secondary stroke prevention following a transient ischemic attack or minor acute ischemic stroke. The risk of recurrent thrombotic events is highest within the ...